Berenberg analyst Conor Siversky upgrades Healthcare Trust (NYSE:HTA) from Hold to Buy.
NGM Biopharmaceuticals Q3 EPS $(0.59) Down From $(0.37) YoY, Sales $7.91M Down From $18.57M YoY
NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.59) per share. This is a 59.46 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $7.91 million in